Postcholecystectomy Syndrome: Clinical Trials

1 trial for Postcholecystectomy Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow Postcholecystectomy Syndrome: new trials by email Literature Review of Postcholecystectomy Syndrome trials Research Report on Postcholecystectomy Syndrome

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 mg Tablets in Healthy Volunteers.
Trimedat® - Irritable Bowel Syndrome, Gallstone Disease
Phase 1RecruitingValenta Pharm JSC362025-11-062026-02-19

Narrower conditions

Biliary Dyskinesia (1)  ·  Cholelithiasis (1)  ·  Gastroesophageal Reflux (1)  ·  Irritable Bowel Syndrome (1)

Broader conditions

Bile Duct Diseases (1)  ·  Biliary Tract Diseases (1)  ·  Colonic Diseases (1)  ·  Colonic Diseases, Functional (1)  ·  Common Bile Duct Diseases (1)  ·  Deglutition Disorders (1)  ·  Digestive System Diseases (1)  ·  Esophageal Diseases (1)  ·  Esophageal Motility Disorders (1)  ·  Gastrointestinal Diseases (1)  ·  Intestinal Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Postoperative Complications (1)

Interventions

Trimebutine (1)

Sponsors

Valenta Pharm JSC (1)

Countries

Russia (1)